The role of KMT2 gene in human tumors

Zhi-Long Zhang1,2, Peng-Fei Yu3, Zhi-Qiang Ling4

  • 1Zhejiang Cancer Institute (Experimental Research Center), Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, PR China.

Insights

Histone methylation, regulated by KMT2 (lysine methyltransferase) genes, is vital for gene expression. KMT2 gene mutations are linked to various cancers, impacting tumor development and prognosis.

Area of Science:

  • Molecular Biology
  • Epigenetics
  • Cancer Genetics

Background:

  • Histone methylation is a key epigenetic mechanism regulating gene transcription.
  • Aberrant methylation-modifying enzymes, including the KMT2 (lysine methyltransferase) family, are implicated in genetic diseases and human cancers.
  • KMT2 proteins regulate essential cellular processes like proliferation, growth, development, and differentiation via gene expression control.

Purpose of the Study:

  • To investigate the clinical characteristics and molecular mechanisms of KMT2 gene mutations in human tumors.
  • To understand the correlation between KMT2 mutation status and tumor occurrence, development, and prognosis.
  • To provide insights for early tumor diagnosis, prognosis, and targeted therapy development.

Main Methods:

  • Literature review of studies on KMT2 gene mutations in various human cancers.
  • Analysis of clinical data and molecular mechanisms associated with KMT2 mutations.
  • Comparative analysis of mutation status across different tumor types.

Main Results:

  • KMT2 gene mutations are frequently observed in diverse human cancers.
  • KMT2 mutation status shows potential correlation with tumor initiation, progression, and patient outcomes.
  • Specific KMT2 mutations may influence cellular functions related to cancer development.

Conclusions:

  • KMT2 gene mutations are significant factors in human tumorigenesis.
  • Understanding KMT2 mutation patterns can aid in predicting tumor behavior and patient prognosis.
  • Further research into KMT2 mutations may facilitate the development of novel targeted cancer therapies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.5K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K